Maharashtra, India

Vijayvitthal Thippannachar Mathad

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Megafine Pharma (P) Ltd.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vijayvitthal Thippannachar Mathad. Retrieved from https://idiyas.com/inventor/vijayvitthal-thippannachar-mathad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Biography of Vijayvitthal Thippannachar Mathad

Introduction: Vijayvitthal Thippannachar Mathad is an accomplished inventor based in Maharashtra, India. He is known for his significant contributions to the field of pharmaceuticals, particularly in the preparation of solifenacin.

Latest Patents: Mathad holds a patent for a method for the preparation of solifenacin and its intermediates. This innovative method involves reacting quinuclidin-3-ol and bis(aryl) carbonate to form a specific compound, which is then treated to produce the Solifenacin base.

Career Highlights: Mathad is currently employed at Megafine Pharma Pvt. Ltd., where he continues to advance his research and development efforts in the pharmaceutical industry. His work has led to the creation of valuable processes and compounds that contribute to medical advancements.

Collaborations: Throughout his career, Mathad has collaborated with notable colleagues, including Navnath Chintaman Niphade and Anil Chaturlal Mali. These partnerships have fostered a productive environment for innovation and development.

Conclusion: Vijayvitthal Thippannachar Mathad's contributions to the field of pharmaceuticals through his inventive methods and collaborations highlight his role as a significant figure in the industry. His work continues to impact the development of important pharmaceutical compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…